Medigene

Medigene EBIT Margin

Delisted·Jul 2, 2026

The EBIT Margin (Operating Margin) of Medigene (MDG1.DE) as of Oct 19, 2026 is -265.96 %. In the previous year, EBIT Margin (Operating Margin) was -27.98 % — a change of 850.42% (lower).

EBIT Margin

-265.96 %

YoY

850.42%

Last updated:

EBIT Margin (Operating Margin) of Medigene is 2023 -265.96 % . EBIT Margin (Operating Margin) of Medigene was 2022 -27.98 % . It decreases by 850.42% lower compared to the previous year.

For Medigene, the operating (EBIT) margin of -266.0% is down versus -189.6% a few years ago.

The Medigene EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2016
-93.36 EUR
Jan 1, 2017
-117.71 EUR
Jan 1, 2018
-229.88 EUR
Jan 1, 2019
-189.63 EUR
Jan 1, 2020
-266.69 EUR
Jan 1, 2021
-95.43 EUR
Jan 1, 2022
-27.98 EUR
Jan 1, 2023
-265.96 EUR
The Medigene EBIT Margin history
YEAREBIT MarginYoY
-265.96 %+850.42%
-27.98 %-70.68%
-95.43 %-64.22%
-266.69 %+40.64%
-189.63 %-17.51%
-229.88 %+95.30%
-117.71 %+26.07%
-93.36 %-39.11%
-153.33 %+633.62%
-20.90 %+1,659.01%
-1.19 %-54.58%
-2.62 %-22.19%
-3.36 %-72.07%
-12.04 %+2,319.38%
-0.50 %-162.17%
0.80 %-160.35%
-1.33 %+395.41%
-0.27 %-54.54%
-0.59 %-47.95%
-1.13 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medigene Stock analysis

What does Medigene do? Medigene AG, based in Planegg, Germany, is a biotechnology company specializing in developing innovative cancer treatment platforms. The company focuses on personalized T cell-based immunotherapies, including TCR-modified T cells for adoptive therapy, dendritic cell vaccines for low tumor burdens, and T-cell-specific monoclonal antibodies. It operates offices in Martinsried, Germany, and in Washington DC and San Diego, USA, with 136 employees. Medigene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medigene stock

EBIT Margin (Operating Margin) of Medigene is -265.96 % in 2023.

EBIT Margin (Operating Margin) of Medigene changed from -27.98 % to -265.96 %, representing a 850.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Medigene since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Medigene with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Medigene

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Medigene